This membrane glycoprotein is involved in glucose and lipid metabolic reprogramming in ccRCC, and reduced patients’ cancer-specific (CSS) and progression-free survival (PFS) were noted in cases of higher levels of CA15-3 (serum form of MUC1) [168,169]. The gene discussed is MUC1; the disease is nonpapillary renal cell carcinoma.